share_log

HC Wainwright & Co. Maintains Buy on Tyra Biosciences, Raises Price Target to $17

Benzinga ·  Mar 7, 2023 06:12

HC Wainwright & Co. analyst Mitchell Kapoor maintains Tyra Biosciences (NASDAQ:TYRA) with a Buy and raises the price target from $15 to $17.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment